Broadcast Pharmaceutical Advertising in the United States
Primetime Pill Pushers
Seiten
2018
Lexington Books (Verlag)
978-1-4985-3953-1 (ISBN)
Lexington Books (Verlag)
978-1-4985-3953-1 (ISBN)
This book analyzes the profit-driven nature of the pharmaceutical industry to explore how healthcare has become commodified in the United States. It addresses how pharmaceutical companies are shaping drug interventions, such as the ways in which pharmaceutical advertisements frame issues of identity and representation for patients and healthcare.
How often do we stop to recognize what pharmaceutical advertisements are telling us? Broadcast Pharmaceutical Advertising in the United States: Prime Time Pill Pushers engages with this question to include how pharmaceutical companies are shaping the meaning of drug interventions for individuals and the ways in which pharmaceutical advertisements frame issues of identity and representation for patients and health care. Such issues highlight how patients are being framed as consumers in these advertisements, which then permits the commodification of health care to be celebrated. Such a celebration has strong ideological implications, including definitions of “the good life,” patient agency, and the role of DTCAs in such depictions. By defining and discussing medicalization, pharmaceuticalization, and commodity fetishism, this book introduces how the term “pharmaceutical fetishism” can act as a means for describing the commodification of brand-name pharmaceutical drugs, which, via advertising and promotional culture, ignores large-scale production and for-profit motives of “big pharma.”
How often do we stop to recognize what pharmaceutical advertisements are telling us? Broadcast Pharmaceutical Advertising in the United States: Prime Time Pill Pushers engages with this question to include how pharmaceutical companies are shaping the meaning of drug interventions for individuals and the ways in which pharmaceutical advertisements frame issues of identity and representation for patients and health care. Such issues highlight how patients are being framed as consumers in these advertisements, which then permits the commodification of health care to be celebrated. Such a celebration has strong ideological implications, including definitions of “the good life,” patient agency, and the role of DTCAs in such depictions. By defining and discussing medicalization, pharmaceuticalization, and commodity fetishism, this book introduces how the term “pharmaceutical fetishism” can act as a means for describing the commodification of brand-name pharmaceutical drugs, which, via advertising and promotional culture, ignores large-scale production and for-profit motives of “big pharma.”
Janelle Applequist is assistant professor at the University of South Florida in the Zimmerman School of Advertising & Mass Communications.
List of Tables
Preface
Acknowledgements
Chapter 1 – The Nature of the Pharmaceutical Advertising Industry: Direct-to-Consumer
Advertising in the United States
Chapter 2 – Theoretical Foundations: Toward an Analysis of DTCA
Chapter 3 – Analyses of DTCA on Primetime Television
Chapter 4 – DTC Advertisements: A Triangulated Approach
Chapter 5 – The Commercial Elements of Constructing a Drug: A Textual Analysis of a Yaz Advertisement
Chapter 6 – Looking Forward
Bibliography
About the Author
| Erscheinungsdatum | 18.09.2018 |
|---|---|
| Zusatzinfo | 12 Tables |
| Sprache | englisch |
| Maße | 151 x 222 mm |
| Gewicht | 249 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Sozialwissenschaften ► Kommunikation / Medien ► Medienwissenschaft | |
| Technik | |
| Wirtschaft ► Betriebswirtschaft / Management ► Marketing / Vertrieb | |
| ISBN-10 | 1-4985-3953-X / 149853953X |
| ISBN-13 | 978-1-4985-3953-1 / 9781498539531 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Steven Spielbergs JAWS und die Geburt eines amerikanischen Albtraums
Buch (2025)
Bertz und Fischer (Verlag)
CHF 41,90
